Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biogen Idec, Inc. (NQ: BIIB)
231.33 USD  +6.15 (+2.73%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 226.17
Bid (Size) 231.33 (200)
Ask (Size) 231.36 (400)
Prev. Close 225.18
Today's Range 226.00 - 234.20
52wk Range 126.39 - 234.46
Shares Outstanding 237,374,815
Dividend Yield N/A
Featured News
More News
Why I stopped using stop loss orders
May 09, 2013
A big problem with stop losses is that you give up control of your sell order. During volatile markets, that can cost you money. But there is an alternative, writes Michael Sincere. Read More
category VRX , Opinion , Commentary , and 12 more.
from MarketWatch
Stock Downgrades: Sky Falls in on Cloud Peak Energy
May 01, 2013
Wall Street ratings agencies set the tone for today's stock market. Read More
category NUAN , LSI , BIIB
from Minyanville Headlines

Featured News
Read More
Biotech’s latest rally: exuberance or execution?
April 26, 2013
category Household Products , Biotechnology , NBI , and 11 more.
from MarketWatch
Thursday movers: Akamai, Cliffs Natural Resources
April 25, 2013
category Computer Software , Biotechnology , Retail , and 22 more.
from MarketWatch
Growth cities rely on the power of people
April 15, 2013
category RTN , General , BIIB
from MarketWatch
Stock Upgrades: Google Is Going Places
February 27, 2013
category YHOO , RSH , NOK , and 2 more.
from Minyanville Headlines
Affymax plunges 85% on recall of anemia drug
February 25, 2013
category Computer Software , Biotechnology , Financial Services , and 21 more.
from MarketWatch
Stock Downgrades: Elan Losing Its Panache
February 11, 2013
from Minyanville Headlines
More News
Read More
49.9% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)
May 21, 2013
from Comtex SmarTrend® News Briefs
Biogen Idec Submits BLA to FDA for Approval of PLEGRIDY for Multiple Sclerosis
May 21, 2013
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 21, 2013
from Business Wire News Releases
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
May 21, 2013
from Business Wire News Releases
Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY™ (Peginterferón Beta-1a) sobre esclerosis múltiple
May 21, 2013
from Business Wire Spanish
Biogen's (BIIB) BG-12 Data Not Inflated
May 20, 2013
from StreetInsider.com News Articles
Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment
May 20, 2013
category Benzinga , News , BIIB , and 2 more.
from Latest Articles from Benzinga.com
Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp
May 20, 2013
from StreetInsider.com News Articles
CORRECTED-Data show new Roche leukemia drug may improve on Rituxan
May 16, 2013
category companyNews
from Reuters: Company News
Data shows new Roche leukemia drug may improve on Rituxan
May 15, 2013
category companyNews
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
6 Healthy Products That Aren't
Diane Bullock
2
The New Microsoft Xbox One: Key Takeaways (and Red Flags) From Today's Announcement
Jake Barach and Nick Shchteko
3
Random Thoughts: A Signal That Bears Watching
Todd Harrison
4
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper

Financial Product Guide